Search filters

List of works by Rupert Sandbrink

250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

scientific article published on 2 September 2009

Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b

scientific article

Efficacy and safety of interferon beta-1b sc in older RRMS patients—a posthoc analysis of the BEYOND study

article

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci

scientific article

Interleukin 17F level and interferon β response in patients with multiple sclerosis

scientific article

Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion: One-Year Results of the Phase 3 GALILEO Study.

scientific article published on 29 September 2013

Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.

scientific article published on 17 October 2012

Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies

scientific article published on 29 September 2013

Molecular mechanism underlying the impact of vitamin D on disease activity of MS.

scientific article

Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial

scientific article published on 27 September 2011

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.

scientific article

Predictors of disease activity in 857 patients with MS treated with interferon beta-1b

scientific article

Variability in detection and quantification of interferon β-1b-induced neutralizing antibodies

scientific article published on 15 June 2012

Vitamin D as an early predictor of multiple sclerosis activity and progression

scientific article published on March 2014